Position in MYGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$57,454
-$416,909 QoQ
Shares Held
10,062
-90.5% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#136
of 197 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Headlands Technologies LLC holds $7,069,211 across 9 Diagnostics & Research names. MYGN ranks #8 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
6,280 | $3,148,540 | |
| 2 | NTRA |
Natera, Inc.
|
5,102 | $1,384,937 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
2,133 | $1,122,896 | |
| 4 | DHR |
Danaher Corp /De/
|
2,440 | $464,771 | |
| 5 | RVTY |
Revvity, Inc.
|
3,330 | $370,495 | |
| 6 | FLGT |
Fulgent Genetics, Inc.
|
17,453 | $358,135 | |
| 7 | OPK |
Opko Health, Inc.
|
107,989 | $161,983 | |
| 8 | MYGN |
Myriad Genetics Inc
This page
|
10,062 | $57,454 |
All Filings in MYGN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $57,454 | 10,062 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $474,363 | 105,414 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $533,770 | 86,792 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $552,299 | 76,390 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $445,609 | 83,919 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $414,468 | 46,727 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $298,452 | 21,769 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $165,380 | 6,038 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $162,023 | 6,624 | Shares | Sole | 2024-08-07 | |
| No filing history on record for this holder in this stock. | ||||||